4-aminobenzoic acid has been researched along with Alloxan Diabetes in 6 studies
para-Aminobenzoates: Benzoic acids, salts, or esters that contain an amino group attached to carbon number 4 of the benzene ring structure.
4-aminobenzoate : An aromatic amino-acid anion that is the conjugate base of 4-aminobenzoic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Type 2 diabetes was induced in adult male rats by high-fructose/high-fat diet and low streptozotocin dose." | 1.46 | PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis. ( Ahmed, AF; Ali, AA; El-Bassossy, HM; El-Maraghy, NN; Zakaria, EM, 2017) |
| "Diabetic nephropathy is the leading cause of end-stage renal disease worldwide, but no effective therapeutic strategy is available." | 1.43 | Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model. ( Ha, H; Jeong, BY; Lee, HB; Lee, JH; Miyata, T; Park, JH; Uddin, MJ, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wen, S | 1 |
| Deng, F | 1 |
| Li, L | 1 |
| Xu, L | 1 |
| Li, X | 1 |
| Fan, Q | 1 |
| Wang, X | 1 |
| Wu, T | 1 |
| Ma, H | 1 |
| Huang, X | 1 |
| Huang, K | 1 |
| Ye, C | 1 |
| Zhu, S | 1 |
| Liu, Z | 1 |
| Benard, O | 1 |
| Syeda, MM | 1 |
| Schuster, VL | 1 |
| Chi, Y | 1 |
| Jeong, BY | 1 |
| Uddin, MJ | 1 |
| Park, JH | 1 |
| Lee, JH | 1 |
| Lee, HB | 1 |
| Miyata, T | 1 |
| Ha, H | 1 |
| Zakaria, EM | 1 |
| El-Maraghy, NN | 1 |
| Ahmed, AF | 1 |
| Ali, AA | 1 |
| El-Bassossy, HM | 1 |
| Otsu, I | 1 |
| Ikebukuro, H | 1 |
| Nozawa, M | 1 |
6 other studies available for 4-aminobenzoic acid and Alloxan Diabetes
| Article | Year |
|---|---|
VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation.
Topics: Animals; Caspase 1; Cell Culture Techniques; Diabetes Mellitus, Experimental; Diabetic Nephropathies | 2022 |
VX-765 ameliorates inflammation and extracellular matrix accumulation by inhibiting the NOX1/ROS/NF-κB pathway in diabetic nephropathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Diabetes Mellitus, Experimental; Diabet | 2022 |
Inhibition of Prostaglandin Transporter (PGT) Promotes Perfusion and Vascularization and Accelerates Wound Healing in Non-Diabetic and Diabetic Rats.
Topics: Animals; Antigens, CD34; Bone Marrow Cells; Cell Line; Diabetes Mellitus, Experimental; Endothelial | 2015 |
Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, A | 2016 |
PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
Topics: Animals; Benzamides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropath | 2017 |
K-MAP prevents cyclosporine toxicity on islet B cells in rat pancreatic transplantation.
Topics: 4-Aminobenzoic Acid; Animals; Blood Glucose; Cyclosporins; Diabetes Mellitus, Experimental; Graft Su | 1991 |